December 23, 2024 06:03 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle

UK gov't secures early access to 90mln doses of domestically-made COVID-19 vaccines

| @indiablooms | Jul 20, 2020, at 10:01 pm

Moscow/Sputnik: The UK government said on Monday it had entered partnerships with local developers of coronavirus vaccines and secured early access to over 90 million doses of three different types of vaccines and treatment for priority patients.

"Millions of people could be vaccinated against coronavirus as the UK secures early access to 90 million doses of promising Covid-19 vaccine candidates," the government said in a press release.

Announced by UK Business Secretary Alok Sharma, as quoted in the press release, the government entered partnerships with three domestic pharmaceutical developers for three different types of COVID-19 vaccines.

"As a result of these partnerships, England, Scotland, Wales and Northern Ireland could have access to enough doses to vaccinate and protect priority groups identified, such as frontline health and social care workers and those at increased health risk," the press release read.

Thirty million doses were secured with the BioNTech and Pfizer partnership developing an mRNA vaccine, which works by introducing sequences of molecules designed to make cells produce disease specific antigens and trigger a regular immune response.

Another 60 million doses of an inactivated whole virus vaccine, with the option to add a further 40 million doses, were secured through an in principle agreement with the Valneva pharmaceutical company.

For patients incapable of taking traditional vaccines, for example due to suffering cancer or autoimmune diseases, the government reached an in principle agreement with AstraZeneca for one million doses of a treatment containing coronavirus neutralizing antibodies.

As part of the same announcement, the UK government said it had opened an online registry where UK nationals can volunteer to participate in clinical trials of candidate vaccines. The hope is to get 500,000 people signed up by October.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.